Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation‐induced apoptosis

• Published in: Arthritis and rheumatism 2005-04, Vol.52 (4), p.1047-1057
• Main Authors: Maas, Kevin, Westfall, Matthew, Pietenpol, Jennifer, Olsen, Nancy J., Aune, Thomas
• Format: Article
• Language: English
• Subjects: Adult; Apoptosis - radiation effects; Arthritis, Rheumatoid - blood; Arthritis, Rheumatoid - pathology; Biological and medical sciences; Cell Survival - radiation effects; Checkpoint Kinase 2; Diseases of the osteoarticular system; DNA Damage; Female; Gamma Rays; Genes, p53 - radiation effects; Humans; Inflammatory joint diseases; Leukocytes, Mononuclear - metabolism; Leukocytes, Mononuclear - pathology; Leukocytes, Mononuclear - radiation effects; Male; Medical sciences; Middle Aged; Protein-Serine-Threonine Kinases - genetics; Protein-Serine-Threonine Kinases - metabolism; Protein-Serine-Threonine Kinases - radiation effects; RNA, Messenger - metabolism; RNA, Messenger - radiation effects; Tumor Suppressor Protein p53 - genetics; Tumor Suppressor Protein p53 - metabolism; Tumor Suppressor Protein p53 - radiation effects
• ISSN: 0004-3591; 1529-0131
• DOI: 10.1002/art.20931

Objective Patients with autoimmune disorders exhibit highly reproducible gene expression profiles in their peripheral blood mononuclear cells. This profile includes, at least in part, a collection of underexpressed genes that encode proteins that inhibit cell cycle progression and stimulate apoptosis. We aimed to determine whether this gene expression profile confers functional liability on lymphocytes from patients with rheumatoid arthritis (RA). Methods Viability studies in response to a panel of proapoptotic stimuli revealed that T lymphocytes from patients with RA were resistant to gamma radiation–induced apoptosis, a process known to be dependent on p53. To assess p53 function in RA peripheral blood mononuclear cells, baseline levels of p53 protein and TP53 transcript were measured in patients with RA and controls. The cellular p53 response to gamma radiation was also assessed by immunoblotting. Results Lymphocytes from patients with RA had lower baseline levels of TP53 messenger RNA (mRNA) and p53 protein than did those from control subjects and were deficient in their ability to increase p53 after exposure to gamma radiation. A subgroup of patients with RA had a second biochemical defect characterized by expression of very low baseline levels of checkpoint kinase 2 mRNA and protein. Conclusion We conclude that defects in the expression of TP53 mRNA and, in a subgroup, defects in expression of CHK2 mRNA, lead to severe defects in apoptosis in patients with RA. We hypothesize that this liability may contribute to autoimmunity.